NIH-funded research Fellowship grant

Creating cancer-fighting drugs using engineered yeast

Official title: Biosynthesis of Cyclopamine and New-to-Nature Triterpenoids in Yeast

Funded at University of California Berkeley · NIH-11007187 · Data updated 2026-11-12

This study is exploring a new way to make helpful cancer-fighting medicines using specially modified yeast, which could lead to more affordable and accessible treatments for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2027
Funding year2025
Award (this year)$74,284
NIH project number5F32GM153046-02
Project IDNIH-11007187 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cancer or those seeking innovative therapies for related conditions.

Less likely to help

Patients who do not have cancer or related conditions may not receive direct benefits from this research.

What this research studies

This research focuses on developing a sustainable method to produce terpenoid drugs, such as cyclopamine, using engineered yeast. By constructing a complete biosynthetic pathway in brewer's yeast, the project aims to produce complex medicinal compounds from simple sugars and salts. This approach is designed to be scalable and cost-effective, potentially leading to more accessible treatments for cancer and other diseases. Patients may benefit from new anti-cancer therapies derived from these naturally occurring compounds.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective and affordable cancer treatments.

How similar studies have gone: Previous research has successfully utilized engineered microorganisms to produce therapeutic compounds, indicating a promising approach for this project.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Winegar, Peter Henry — University of California Berkeley
  • Study coordinator: Winegar, Peter Henry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.